• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Celotres hydrogel scaffold wins CE mark OK

Article

Drugmaker Halscion announced that its product Celotres has received European CE mark approval. Celotres is a hydrogel scaffold used to improve wound healing and scarring.

Suwanee, Ga. - Drugmaker Halscion announced that its product Celotres has received European CE mark approval. Celotres is a hydrogel scaffold used to improve wound healing and scarring.

Celotres received the CE mark approval based on the successful results of European clinical trials. The trials were conducted among 100 female patients undergoing laparotomy or laparoscopy gynecologic procedures, and showed that after 12 months, the scars treated with Celotres were evaluated by both observers and subjects as appearing significantly better using both the Patient and Observer Scar Assessment Scale and the Anchored Visual Analog Scale.

There were no serious device-related adverse events reported with Celotres use and an evaluation of all adverse events showed no difference between treatment and control for any event.

“We are pleased to reach this significant milestone for Halscion and look forward to making Celotres available to European physicians this year,” said Kathleen Beauchamp, president and CEO of Halscion.

The CE mark shows that a product conforms to consumer laws for the entire European Economic Area and allows a product to be sold among all nations in the confederation.

Go back to the Dermatology Times eNews newsletter.

Related Videos
Video 3 - featuring 2 panelists in, "Navigating Treatment Challenges: Addressing Negative Responses and Determining the Next Course of Action "
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Video 2 - "Optimizing Long-Term Care: Physician Insights on Secondary Dermatitis Management" - 2 KOLs in this video.
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Video 4 - "Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care " - 1 KOL in this panel
© 2024 MJH Life Sciences

All rights reserved.